AOA Dx
Blood Test for Early Detection of Ovarian Cancer
About AOA Dx
AOA Dx is developing the next frontier in early-stage cancer detection for women through our pioneering work in glycolipids and proprietary biomarker technology.
Company details
Funding
Total raised
$30.1M
Last stage
Series B
Investors
Founders
Alex Fisher
Chief Operating Officer and Co-Founder of AOA Dx. Passionate about improving women's health.
Oriana Papin-Zoghbi
Visionary leader in women's health and diagnostics; honored in Inc.'s 2022 Top 100 Female Founders. Previously co-founded two successful women's health diagnostic startups with strategic exits.
LinkedInAnna Jeter
Chief Business Officer & Co-Founder
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.